Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01451411 · ClinicalTrials.gov registry record · Phase 3
A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia
A Phase 3 study, sponsored by Cumberland Pharmaceuticals.
- Terminated
- Registry status
- Phase 3
- Development phase
- 4
- Enrollment target
NCT01451411: Clinical Trial Phase 3 study, sponsored by Cumberland Pharmaceuticals.
NCT01451411 is a Phase 3 study that was terminated before completion, run by Cumberland Pharmaceuticals. The registered enrollment target is 4 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01451411, a Phase 3 study, was terminated before completion, sponsored by Cumberland Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 4 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the efficacy, safety and pharmacokinetics of intravenous conivaptan in pediatric subjects with abnormally low concentration of sodium in blood.
Interventions
- DRUG Placebo
- DRUG Conivaptan hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-01 |
| Phase | Phase 3 |
Why NCT01451411 stopped before completion
NCT01451411 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01451411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01451411 about?
NCT01451411 is a clinical study titled "A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia". The objective of this study is to evaluate the efficacy, safety and pharmacokinetics of intravenous conivaptan in pediatric subjects with abnormally low concentration of sodium in blood.
What is the current status of trial NCT01451411?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 4 participants. The study started on 2012-02. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01451411?
The interventions under investigation include: Placebo (DRUG), Conivaptan hydrochloride (DRUG).
Who is sponsoring clinical trial NCT01451411?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01451411's enrollment target sits among peer trials
4 1998th of 2000 higher than 2 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia